June 6, 2024 · Form 4 insider transaction
THOMAS PAUL bought 10,653 shares of AxoGen, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.